Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry

Bodur, Hatice; Yurdakul, Fatma Gul; ATAMAN, ŞEBNEM; Cay, Hasan Fatih; GÜRER, GÜLCAN; ÇAPKIN, ERHAN; SEZER, İLHAN; DURUÖZ, MEHMET TUNCAY; Alkan Melikoğlu, Meltem; Rezvani, Aylin; YAĞCI, İLKER; GÖĞÜŞ, FERİDE NUR; KAMANLI, AYHAN; AKGÜL, ÖZGÜR; ÇEVİK, REMZİ

doi:10.1007/s10067-022-06145-8

Makale Tam Makale Uluslararası 2022

Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry

Hatice Bodur, Fatma Gul Yurdakul, ŞEBNEM ATAMAN, Hasan Fatih Cay, GÜLCAN GÜRER, ERHAN ÇAPKIN, İLHAN SEZER, MEHMET TUNCAY DURUÖZ, Meltem Alkan Melikoğlu, Aylin Rezvani, İLKER YAĞCI, FERİDE NUR GÖĞÜŞ, AYHAN KAMANLI, ÖZGÜR AKGÜL, REMZİ ÇEVİK

CLINICAL RHEUMATOLOGY Cilt 41 · Sayı 7 · ss. 2053–2063 · 01.07.2022

DOI ile aç

Özet

Objectives Factors associated with disease activity of axial spondyloarthritis (axSpA) and switching of biologic disease-modifying anti-rheumatic drugs have not been clearly defined. We aimed to evaluate clinical characteristics of patients with axSpA, factors related to remission in treat to target era and predictive factors for biologic disease-modifying anti-rheumatic drug switching.

Anahtar kelimeler

THERAPY ankylosing spondylitis disease activity INHIBITORS Spondyloarthritis Disease modifying anti rheumatic drugs Drug switching Remission induction HLA-B27

Atıf için künye

Bodur, H., Yurdakul, F. G., ATAMAN, Ş., Cay, H. F., GÜRER, G., ÇAPKIN, E., SEZER, İ., DURUÖZ, M. T., Alkan Melikoğlu, M., Rezvani, A., YAĞCI, İ., GÖĞÜŞ, F. N., KAMANLI, A., AKGÜL, Ö., & ÇEVİK, R. (2022). Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry. CLINICAL RHEUMATOLOGY, 41(7), 2053–2063. https://doi.org/10.1007/s10067-022-06145-8

BibTeX

@article{bodur2022-226209,
  author = {Bodur, Hatice and Yurdakul, Fatma Gul and ATAMAN, ŞEBNEM and Cay, Hasan Fatih and GÜRER, GÜLCAN and ÇAPKIN, ERHAN and SEZER, İLHAN and DURUÖZ, MEHMET TUNCAY and Alkan Melikoğlu, Meltem and Rezvani, Aylin and YAĞCI, İLKER and GÖĞÜŞ, FERİDE NUR and KAMANLI, AYHAN and AKGÜL, ÖZGÜR and ÇEVİK, REMZİ},
  title = {Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry},
  journal = {CLINICAL RHEUMATOLOGY},
  year = {2022},
  volume = {41},
  number = {7},
  pages = {2053--2063},
  issn = {0770-3198},
  doi = {10.1007/s10067-022-06145-8},
  url = {https://akademik.atauni.edu.tr/yayinlar/226209-where-we-are-in-treat-to-target-era-predictive-factors-for-remission-and-drug}
}